SYNTHESIS OF UNUSUAL BIOLOGICALLY ACTIVE TERPENES
SYNTHESIS OF UNUSUAL BIOLOGICALLY ACTIVE TERPENES
批准号:
3278724
负责人:
LEO A PAQUETTE
金额:
$20.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-04-01 至 1995-03-31
中文摘要
这项研究的主要目标是继续发展,
高级水平的实用性[3,3] sigmatropy的建设,
结构类型多种多样的复杂萜烯。 这种方法
所有的迹象都表明这是一个非常重要的进步,
以一种简洁和
立体控制方式 这些新战略是基于进一步
利用阴离子氧-Cope和Claisen重排进行共-
结构不寻常的中型环系统组成的7-10
组成原子。 许多选定的潜在适用性
针对不同治疗领域的目标,
特别及时,是重要的补充理由。
一种利用串联技术合成黑色素B3的非常短的方法
动力学拆分和氧代Cope化学来构建中心
以立体控制的方式与适当的绝对
将检查配置。 同样,一个特别短的
一种快速构建桥头的脆化剂的合成方法
烯属烯丙基氢过氧化物被计划。 高度的趋同
描述了计划中的精加工蛋白酸和乙烯基酚的特性。 这
整个阴离子氧-Cope工艺的方面已经严重地
在过去的研究中被忽视,值得大量开发。 的
复杂的分子可以通过这种方式进行加工的速度
技术可能是无与伦比的。
这一策略也将在我们计划的方法中得到应用,
维雷西那明A.在这种情况下,两个必要的建筑之一,
Blocks是天然存在的呋喃萜类吴茱萸酮。 在所有
在上述推力下,可以制备类似物以提供添加的
了解各自协议的灵活性。
扩大克莱森环的重新安排预计将促进
快速控制几种劳伦辛代谢物如劳伦炔和
异aureatin,以及尤加利烷的氧杂双环二萜类化合物
类型. 一种涉及新的双重Tebbe-Claisen序列的方法是,
开发并扩展到合成ceroplastrin I。最后,
脂环克莱森重排的双重采用是作为
是合成cleomdolide的关键立体化学决定因素。
英文摘要
The primary objective of this research is to continue to develop at an
advanced level the utility of [3,3] sigmatropy for the construction of
complex terpenes of widely varied structural type. This methodology
gives every indication of being a very important advance in our ability
to access diverse classes of important natural products in a concise and
stereocontrolled manner. These new strategies are based on the further
exploitation of the anionic oxy-Cope and Claisen rearrangements for con-
struction of unusual medium-sized ring systems consisting of 7-10
constituent atoms. The latent applicability of many of the selected
targets to various therapeutic areas make this phase of the program
particularly timely and constitutes important added justification.
An exceptionally short synthesis of cyathin B3 which exploits tandem
kinetic resolution and oxy-Cope chemistry to construct the central
seven-membered ring in stereocontrolled fashion with proper absolute
configuration will be examined. In like fashion, an exceptionally short
synthesis of crispolide that features rapid construction of bridgehead
olefinic allylic hydroperoxides is planned. High levels of convergency
characterize the planned elaboration of albolic acid and vinigrol. This
aspect of the overall anionic oxy-Cope process has been seriously
neglected in past studies and warrants considerable exploitation. The
rapidity with which complex molecules can be elaborated by this
technique is probably unrivaled.
This tactic will also see service in our planned approach to
verecynarmin A. In this instance, one of the two necessary building
blocks is the naturally occurring furanoterpene evodone. In all of the
above thrusts, analogues may be prepared in order o provide added
insight into the flexibility of the respective protocols.
Ring-expanding Claisen rearrangements are expected to facilitate the
rapid contruction of several laurencin metabolites such as laurenyne and
isolaureatin, as well as oxabicyclic diterpenoids of the eunicellane
type. A process involving a novel two-fold Tebbe-Claisen sequence is to
be developed and extended to a synthesis of ceroplastol I. Finally,
two-fold adoption of the alicyclic Claisen rearrangement is to serve as
the key stereochemical determinant in a projected route to cleomdolide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
-
批准号:6416187
-
项目类别:
-
资助金额:$5.37万
-
财政年份:2000
-
负责人:LEO A PAQUETTE
-
依托单位:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
-
批准号:6559330
-
项目类别:
-
资助金额:$6.2万
-
财政年份:2000
-
负责人:LEO A PAQUETTE
-
依托单位:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
-
批准号:6350406
-
项目类别:
-
资助金额:$25.97万
-
财政年份:2000
-
负责人:LEO A PAQUETTE
-
依托单位:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
-
批准号:6027868
-
项目类别:
-
资助金额:$26.06万
-
财政年份:2000
-
负责人:LEO A PAQUETTE
-
依托单位:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
-
批准号:6551975
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2000
-
负责人:LEO A PAQUETTE
-
依托单位:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
-
批准号:6497941
-
项目类别:
-
资助金额:$26.8万
-
财政年份:2000
-
负责人:LEO A PAQUETTE
-
依托单位:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
-
批准号:6628425
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2000
-
负责人:LEO A PAQUETTE
-
依托单位:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
-
批准号:2105131
-
项目类别:
-
资助金额:$24.13万
-
财政年份:1995
-
负责人:LEO A PAQUETTE
-
依托单位:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
-
批准号:2008491
-
项目类别:
-
资助金额:$25.17万
-
财政年份:1995
-
负责人:LEO A PAQUETTE
-
依托单位:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
-
批准号:2105130
-
项目类别:
-
资助金额:$24.18万
-
财政年份:1995
-
负责人:LEO A PAQUETTE
-
依托单位:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
-
批准号:2405847
-
项目类别:
-
资助金额:$7.16万
-
财政年份:1995
-
负责人:LEO A PAQUETTE
-
依托单位:
MEDICINAL CHEMISTRY A STUDY SECTION
-
批准号:3555185
-
项目类别:
-
资助金额:$6.74万
-
财政年份:1986
-
负责人:LEO A PAQUETTE
-
依托单位:
SINGLE CRYSTAL X-RAY DIFFRACTION FACILITY
-
批准号:3519362
-
项目类别:
-
资助金额:$23.4万
-
财政年份:1986
-
负责人:LEO A PAQUETTE
-
依托单位:
MEDICINAL CHEMISTRY A STUDY SECTION
-
批准号:3555183
-
项目类别:
-
资助金额:$9.0万
-
财政年份:1986
-
负责人:LEO A PAQUETTE
-
依托单位:
SYNTHESIS OF UNUSUAL BIOLOGICALLY ACTIVE TERPENES
-
批准号:2175927
-
项目类别:
-
资助金额:$22.17万
-
财政年份:1983
-
负责人:LEO A PAQUETTE
-
依托单位:
SYNTHESES OF UNUSUAL BIOLOGICALLY ACTIVE TERPENES
-
批准号:3278722
-
项目类别:
-
资助金额:$16.66万
-
财政年份:1983
-
负责人:LEO A PAQUETTE
-
依托单位:
SYNTHESES OF UNUSUAL BIOLOGICALLY ACTIVE TERPENES
-
批准号:3278721
-
项目类别:
-
资助金额:$16.0万
-
财政年份:1983
-
负责人:LEO A PAQUETTE
-
依托单位:
SYNTHESIS OF UNUSUAL BIOLOGICALLY ACTIVE TERPENES
-
批准号:3278719
-
项目类别:
-
资助金额:$15.83万
-
财政年份:1983
-
负责人:LEO A PAQUETTE
-
依托单位:
SYNTHESES OF UNUSUAL BIOLOGICALLY ACTIVE TERPENES
-
批准号:3278723
-
项目类别:
-
资助金额:$17.7万
-
财政年份:1983
-
负责人:LEO A PAQUETTE
-
依托单位:
SYNTHESIS OF UNUSUAL BIOLOGICALLY ACTIVE TERPENES
-
批准号:3278725
-
项目类别:
-
资助金额:$21.44万
-
财政年份:1983
-
负责人:LEO A PAQUETTE
-
依托单位: